Biondo Investment Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Biondo Investment Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,225	Closed	-$513K	–	98
2017 Q4	$513K	Buy	+11,225	New	+$560K	0.13%	67

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Biondo Investment Advisors's JUNO Position: Q1 2018 in Review

Biondo Investment Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 11,225 shares — an estimated $513K sold.

Biondo Investment Advisors first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $513K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Biondo Investment Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Biondo Investment Advisors sold 11,225 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $513K.
Biondo Investment Advisors first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Biondo Investment Advisors's Juno Therapeutics, Inc. position peaked at $513K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Biondo Investment Advisors's 13F filing for Q1 2018, filed 2 May 2018.